Related Experiment Video

Updated: Jul 1, 2025

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

19.6K

Cancer biology in diabetes update: Focusing on antidiabetic drugs

Emi Kawakita1, Keizo Kanasaki1,2

  • 1Department of Internal Medicine 1, Faculty of Medicine, Shimane University, Izumo, Japan.

Journal of Diabetes Investigation
|March 8, 2024
PubMed

Insights

The link between type 2 diabetes and cancer risk is known, but the impact of diabetes medications on cancer development remains unclear. This review examines how antidiabetic drugs may affect cancer initiation, promotion, and progression.

Area of Science:

  • Endocrinology
  • Oncology
  • Pharmacology

Background:

  • Type 2 diabetes is associated with increased risk for certain cancers.
  • The influence of diabetes medications on cancer development is not fully understood.
  • Preclinical studies suggest antidiabetic drugs may affect carcinogenesis beyond glycemic control.

Purpose of the Study:

  • To review the potential impact of various diabetes therapies on cancer initiation, promotion, and progression.
  • To highlight the need for careful consideration when prescribing antidiabetic agents to patients with existing tumors.

Main Methods:

  • Literature review of prospective clinical trials and preclinical studies.
  • Discussion of the influence of antidiabetic therapies on cancer biology.

Main Results:

  • The long-term effects of hypoglycemic drugs on cancer incidence are not elucidated by clinical trials.
  • Antidiabetic drugs may influence carcinogenesis through mechanisms independent of glycemic control.
  • Evidence regarding the safety profile of antidiabetic agents in cancer patients is lacking.

Conclusions:

  • Further research is needed to understand the complex relationship between diabetes medications and cancer.
  • Prescribing antidiabetic drugs to patients with diabetes and cancer requires careful consideration of potential oncogenic effects.
Keywords:
Antidiabetic drugsCancerDiabetes

More Related Videos

Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tgfli:EGFP Zebrafish Retinal Vasculature10:07

Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tgfli:EGFP Zebrafish Retinal Vasculature

Published on: December 26, 2017

13.2K
Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

588

Related Concept Videos

Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
29
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
199
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.1K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
928
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
282